DUBLIN, Ireland, July 19, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue a press release detailing its second quarter 2013 financial results after the market close on Wednesday, July 24, 2013.
Although the Company will not be hosting a quarterly conference call, investors and other interested parties may access the press release by visiting http://ir.wcrx.com and clicking on Press Releases.
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-F
CONTACT: Rochelle Fuhrmann Senior Vice President, Finance 973-442-3281 firstname.lastname@example.org Kevin Crissey Director, Investor Relations 973-907-7084 Kevin.Crissey@wcrx.com
|Aurora announces release date for second quarter 2013 financial results and market briefing conference call ()|
|Carmanah Announces Release Date for Second Quarter 2013 Financial Results and Conference Call ()|
|Ultrapetrol Announces Release Date for Second Quarter 2013 Financial Results and Hosting of Conference Call ()|
|Getty Realty Corp. Announces Earnings Release Date and Second Quarter Earnings Conference Call ()|
|Coleman Cable, Inc. Announces Dates for Second-Quarter 2013 Financial Results Press Release and Conference Call Webcast ()|
|ArthroCare Announces Date for Second Quarter 2013 Financial Results Press Release and Conference Call ()|
|China Housing Announces Earnings Date for Second Quarter 2013 Financial Results ()|
|VIVUS Announces Date of Second Quarter 2013 Financial Results and Conference Call ()|
|Alacer Gold announces release date for third quarter 2013 financial results and conference call (2013/10/16)|
|SciQuest Announces Date for Second Quarter 2013 Financial Results ()|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.